Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation [NA]

View source ↗

Summary

This clinical trial is currently recruiting to compare oxybutynin with transcutaneous neurostimulation for pediatric overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oxybutynin (oxybutynin)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Overactive Bladder (OAB), Transcutaneous Neurostimulation | NA | Status: RECRUITING